Perfluorooctylbromide-loaded fucoidan-chlorin e6 nanoparticles for tumor-targeted photodynamic therapy

Int J Biol Macromol. 2022 Dec 31;223(Pt A):77-86. doi: 10.1016/j.ijbiomac.2022.10.254. Epub 2022 Nov 4.

Abstract

Efficient delivery of a photosensitizer (PS) and oxygen to tumor tissue is critical for successful photodynamic therapy (PDT). For this purpose, we developed a fucoidan (Fu)-chlorin e6 (Ce6) nanoparticle (NP) containing perfluorooctylbromide (PFOB). Fu, a biopolymer derived from seaweed, made up the hydrophilic shell of the NP and provided specific targeting to tumor cells by P-selectin binding. Conjugation with the hydrophobic Ce6 enabled self-assembly and Ce6-generated cytotoxic reactive oxygen species to kill tumor cells upon laser irradiation. PF supplied oxygen to the hypoxic tumor tissue and increased the efficacy of the PDT. The developed Fu-Ce6-PF-NPs bound specifically to SCC7 tumor cells and killed them via a photodynamic effect on laser irradiation. High accumulation of the NPs in tumor tissue and improved tumor suppression by PDT were observed in SCC7 tumor-bearing mice. The overall data demonstrated the potential of Fu-Ce6-PF-NP as a tumor-targeting drug carrier for effective PDT.

Keywords: Fucoidan; Nanoparticle; Perfluorocarbon; Photodynamic therapy; Tumor-targeting.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Mice
  • Nanoparticles* / chemistry
  • Oxygen
  • Photochemotherapy*
  • Photosensitizing Agents / chemistry
  • Porphyrins* / chemistry

Substances

  • Porphyrins
  • Photosensitizing Agents
  • Oxygen